JoVE - Journal of Visualized Experiments
JoVE Visualize
Contact Us

Elucidating the mechanistic role of ovarian cancer biomarkers: Lessons learnt from affinity-proteomics

  • 0Translational Oncology Group, Center for Tumor Biology and Immunology, Philipps University, Marburg, Germany.
Critical Reviews in Oncology/hematology +

|

July 2, 2025

|

July 2, 2025

View abstract on PubMed

Summary

This summary is machine-generated.

Ovarian carcinoma (OC) research focuses on its unique tumor microenvironment (TME) and ascites. Novel affinity-based proteomics aids in discovering biomarkers for early diagnosis and targeted therapies.

Area Of Science

  • Oncology
  • Proteomics
  • Biomarker Discovery

Background

  • Ovarian carcinoma (OC) is the deadliest gynecological malignancy due to its unique tumor microenvironment (TME), early metastasis via ascites, late diagnosis, and chemoresistance.
  • Identifying diagnostic biomarkers for early and recurrent OC is a significant unmet medical need.
  • Ascites fluid offers a rich source for analyzing the tumor secretome, including cells and soluble factors, for biomarker discovery.

Purpose Of The Study

  • To decipher mechanisms of OC progression and metastasis.
  • To identify clinically relevant biomarkers from the TME, particularly from ascites.
  • To leverage novel proteomic approaches for enhanced biomarker discovery and understanding of TME crosstalk.

Main Methods

  • Analysis of the ascites proteome to understand the tumor secretome.
  • Application of affinity-based proteomics for high-throughput and sensitive biomarker detection.
  • Investigation of intercellular crosstalk within the OC TME.

Main Results

  • Previous mass-spectrometry studies have not yet yielded clinically integrated biomarkers.
  • Affinity-based proteomics has revolutionized biomarker research in OC.
  • Key findings from these approaches are discussed regarding TME intercellular communication and novel biomarker identification.

Conclusions

  • Understanding biomarker origin, function, and clinical impact is crucial for OC research.
  • Novel biomarkers can improve the depiction of intercellular communication within the OC TME.
  • This research aims to develop targeted therapies and improved diagnostic tools for ovarian carcinoma.

Keywords: